This brand name is authorized in Austria, Estonia, Spain, Finland, Croatia, Ireland, Lithuania, Poland, Romania, United Kingdom, United States
The drug DOPTELET contains one active pharmaceutical ingredient (API):
|
1
Avatrombopag
UNII GDW7M2P1IS - AVATROMBOPAG MALEATE
|
|
Avatrombopag is an orally active, small molecule thrombopoietin (TPO) receptor agonist that stimulates proliferation and differentiation of megakaryocytes from bone marrow progenitor cells resulting in increased production of platelets. Avatrombopag does not compete with TPO for binding to the TPO receptor and has an additive effect with TPO on platelet production. |
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| DOPTELET Film-coated tablet | European Medicines Agency (EU) | MPI, EU: SmPC | |
| DOPTELET Film-coated tablet | FDA, National Drug Code (US) | MPI, US: SPL/PLR |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC code | Group title | Classification |
|---|---|---|
| B02BX08 | B Blood and blood forming organs → B02 Antihemorrhagics → B02B Vitamin K and other hemostatics → B02BX Other systemic hemostatics | |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: EE | Ravimiamet | Identifier(s): 1798678, 1798689, 1888533 |
| Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 1191373 |
| Country: FI | Lääkealan turvallisuus- ja kehittämiskeskus | Identifier(s): 113364, 498007, 556341 |
| Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 388232, 388234, 393009 |
| Country: IE | Health Products Regulatory Authority | Identifier(s): 89034, 89035, 89098 |
| Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1088088, 1088089, 1091786 |
| Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100423565 |
| Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W67183001, W67183002, W67183003 |
| Country: US | FDA, National Drug Code | Identifier(s): 71369-020 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
